LUCAR-20SP

· Peking University Cancer Hospital & Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LUCAR-20SP, covering 2025-03-25 to 2025-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]